Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Novel Mobile Phone-Based Intervention: Study Design of a Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The widespread and increasing use of oral anti-cancer medications has been ushered in by a rapidly increasing understanding of cancer pathophysiology. Furthermore, their popular ease of administration and potential cost savings has highlighted their central position in the health care system as a whole. These facts have heightened appreciation of the unique challenges associated with the use of oral anti-cancer medications; especially in the long-term use of these medications and the associated side effects that may impede optimal adherence to their use. Therefore, we developed ChemOtheRapy Assistant, CORA, a personalized mobile phone-based self-management application to help cancer patients on oral anti-cancer medications. OBJECTIVE: Our objective is to evaluate the effect of CORA on adherence to oral anti-cancer medications and other clinically relevant outcomes in the management of patients with renal and prostate cancer. METHODS: The study will be implemented as a 2-parallel group randomized controlled trial in 104 patients with renal or prostate cancer on oral anti-cancer medications over a 3-month study period. The intervention group will use CORA in addition to usual care for self-management while the control group will continue care as usual. Medication adherence will be measured objectively by a Medication Event Monitoring System device and is defined as the percentage of prescribed doses taken. We will also assess the effect of the intervention on cancer-related symptoms measured by the MD Anderson Symptom Inventory and unplanned hospital utilizations. Other outcomes that will be measured at study start, midpoint, and endpoint are health-related quality of life, cancer-related fatigue, and anxiety. Group differences in medication adherence will be examined by t tests or by non-parametric Mann-Whitney tests if the data are not normally distributed. Logistic regression will be used to identify potential predictors of adherence. RESULTS: We expect to have results for this study before the end of 2016. CONCLUSIONS: This novel mobile phone-enabled, multimodal self-management and educational intervention could lead to improvements in clinical outcomes and serve as a foundation for future mHealth research in improving outcomes for patients on oral anti-cancer medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877 · cited 1×
“Additionally, we will also use a patient self-report tool, the Morisky Medication Adherence Scale (MMAS-8) to measure medication adherence [21].”
RetractedThe PHQ-8 as a measure of current depression in the general population
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.026 · Cited by 5,121 · cited 2×
“technology use information, and the Patient-Health Questionnaire (PHQ-8) [18], which will be used as a screener for depression, a potential confounder in this study.”
Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008) · Medical Care · doi:10.1097/mlr.0b013e318160d093 · Cited by 4,527 · cited 1×
“• Anxiety: The Generalized Anxiety Disorder 7-Item Scale (GAD-7) will be used to assess anxiety [25].”
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569 · cited 1×
“Studies have reported variable medication adherence rates in cancer patients on OAM regimens, with adherence rates ranging from less than 20% to 100% [5,6].”
Armstrong, A. W., Watson, A. J., Makredes, M., Frangos, J. E., Kimball, A. B., & Kvedar, J. C. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.269 · Cited by 235 · cited 1×
“We expect that this intervention, delivered through a mobile device, compatible with both iOS and Android devices, will forge engagement to improve outcomes similar to those seen in chronic disease management programs [13-15].”
Self-citationVerbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., & Van Hecke, A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.12.014 · Cited by 202
Park, L. G., Howie‐Esquivel, J., & Dracup, K. (2014) · Journal of Advanced Nursing · doi:10.1111/jan.12400 · Cited by 166 · cited 1×
“We expect that this intervention, delivered through a mobile device, compatible with both iOS and Android devices, will forge engagement to improve outcomes similar to those seen in chronic disease management programs [13-15].”
Clifford, S., Perez-Nieves, M., Skalicky, A. M., Reaney, M., & Coyne, K. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.884491 · Cited by 99 · cited 1×
“Currently, there is no gold standard measure of medication adherence, but the MEMS has been used extensively in medication adherence studies [19,20].”
Cited by
Noah, B., Keller, M. S., Mosadeghi, S., Stein, L., Johl, S., Delshad, S., Tashjian, V. C., Lew, D., Kwan, J. T., Jusufagic, A., et al. (2018) · npj Digital Medicine · doi:10.1038/s41746-017-0002-4 · Cited by 273
Seiler, A., Klaas, V., Tröster, G., & Fagundes, C. P. (2017) · Psycho-Oncology · doi:10.1002/pon.4489 · Cited by 176
da Silva, H. E. C., Santos, G. N. M., Ferreira Leite, A., Mesquita, C. R. M., de Souza Figueiredo, P. T., Miron Stefani, C., & de Santos Melo, N. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07109-z · Cited by 24
Pham, Q., Cafazzo, J. A., & Feifer, A. (2017) · JMIR Research Protocols · doi:10.2196/resprot.8051 · Cited by 22
“This has been complemented by work in Web-based education programs for prostate cancer survivors transitioning from active treatment [20], as well as mobile phone-based interventions to increase adherence to oral antiprostate cancer medications [21].”
Metadata
- Authors
- Agboola, S., Flanagan, C., Searl, M., Elfiky, A., Kvedar, J., & Jethwani, K.
- Venue
- JMIR Research Protocols
- Publisher
- JMIR Publications Inc.
- Published
- 2014-12-23
- Volume
- 3
- Issue
- 4
- Pages
- e79
- ISSN
- 1929-0748 (ISSN-L)
- OpenAlex
- W1991213417
- Cited by
- 35
- References
- 8
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Novel Mobile Phone-Based Intervention: Study Design of a Randomized Controlled Trial. https://app.cochat.ai/papers/10.2196/resprot.4041
- The paper
- Agboola, S., Flanagan, C., Searl, M., Elfiky, A., Kvedar, J., & Jethwani, K. (2014). Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Novel Mobile Phone-Based Intervention: Study Design of a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/resprot.4041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.